Numinus Wellness Inc
Change company Symbol lookup
Select an option...
NUMIF Numinus Wellness Inc
RNWWW ReNew Energy Global Equity Warrant Exp 23rd Aug 2026 *W EXP 08/23/2026
RVPH Reviva Pharmaceuticals Holdings, Inc.
TPR Tapestry Inc
BGRY Berkshire Grey Inc
BKNG Booking Holdings Inc
UHT Universal Health Realty Income Trust
BBVA Banco Bilbao Vizcaya Argentaria SA
RILY B Riley Financial Inc
WTS Watts Water Technologies Inc
Go

Health Care : Pharmaceuticals | Small Cap Growth
Based in Canada
Company profile

Numinus Wellness Inc. is a Canada-based mental health care company. The Company develops proprietary, psychedelic-centered, therapeutic products and services through its own laboratory and research and development processes. The Company operates through three segments: Research Operations, the Canadian Clinic Network, and the U.S. Clinic Network. Its Research Operations is focused on licensed psychedelic research and provides clinical research management services to academic institutions and biotechnology companies. The Canadian clinic network consists of Numinus Health Corp., Mindspace, and the NCT. It offers services, such as ketamine-assisted psychotherapy (KAP) for depression, neurological care and psychotherapy and counseling by registered psychologists. The U.S. Clinic Network consists of Cedar Psychiatry and Foundations for Change. It offers services, such as KAP for depression and psychotherapy and counseling by registered psychologists in the United States.

Closing Price
$0.2059
Day's Change
0.0038 (1.89%)
Bid
--
Ask
--
B/A Size
--
Day's High
0.217
Day's Low
0.20
Volume
(Heavy Day)
Volume:
113,550

10-day average volume:
87,332
113,550

Company Profile

Numinus Wellness Inc. is a Canada-based mental health care company. The Company develops proprietary, psychedelic-centered, therapeutic products and services through its own laboratory and research and development processes. The Company operates through three segments: Research Operations, the Canadian Clinic Network, and the U.S. Clinic Network. Its Research Operations is focused on licensed psychedelic research and provides clinical research management services to academic institutions and biotechnology companies. The Canadian clinic network consists of Numinus Health Corp., Mindspace, and the NCT. It offers services, such as ketamine-assisted psychotherapy (KAP) for depression, neurological care and psychotherapy and counseling by registered psychologists. The U.S. Clinic Network consists of Cedar Psychiatry and Foundations for Change. It offers services, such as KAP for depression and psychotherapy and counseling by registered psychologists in the United States.

Valuation Ratios

Price/Earnings (TTM)
--
Price/Sales (TTM)
6.35x
Price/Book (MRQ)
1.99x
Price/Cash Flow (TTM)
--
TTM = Trailing Twelve Months
MRQ = Most Recent Quarter

Price Performance

Historic Growth and Share Detail

Historic Growth

No historic growth available.

Short Interest

No short interest available.

Share Information

NUMIF is in a share class of common stock
Float
243.1M
Shares Outstanding
262.7M
Institutions Holding Shares
5
3.03%

Financial Statements

Balance sheet

Values displayed are in thousands.

Income statement

Values displayed are in thousands.

Cash flow

Values displayed are in thousands.

Company Officers

No company officers listed.

Address

  • 33 Water St., Suite 801
  • Vancouver, BC V6B 1R4
  • Canada
  • Phone: 6043292079
  • Fax: 6043292079
  • https://numinus.com/

Insider Trading

No insider trading activity.

Market data accompanied by is delayed by at least 15 minutes for NASDAQ, NYSE MKT, NYSE, and options. Duration of the delay for other exchanges varies.
Market data and information provided by Morningstar.

Insider trading information report provided by Copyright © 2023. All rights reserved.

Reuters content is the intellectual property of Reuters. Any copying, republication or redistribution of Reuters content, including by caching, framing or similar means, is expressly prohibited without the prior written consent of Reuters. Reuters is not liable for any errors or delays in content, or for any actions taken in reliance on any content. Reuters, Reuters Logo and the Sphere Logo are trademarks and registered trademarks of the Reuters Group of companies around the world.

Data is provided for information purposes only and is not intended for trading purposes. Reuters shall not be liable for any errors or delay in the content, or for any action taken in reliance on any content. The RIC or Reuters Instrument Code set has been developed and maintained by Reuters and is the intellectual property of Reuters.